Antimicrobial peptides (AMPs) are a unique class of molecules that have the capacity to kill a wide variety of microorganisms. These molecules are produced by most living organisms as a form of defense against invading pathogens. They are among the most effective natural killing agents known and are important components of the immune systems of many organisms.
The usage of AMPs has recently been expanding greatly due to increasing global problems related to antibiotic resistance. Triggered by a variety of pressing environmental and safety concerns, non-antibiotic alternatives, like AMPs, are being increasingly sought to combat common bacterial infections that have become resistant to conventional antibiotic therapies. In addition to their use in treatment and prophylaxis, AMPs are also increasingly being studied for their use in sterilizing medical instruments, preserving food, and controlling disease-causing microorganisms in agricultural production.
A global overview of the current AMP market reveals that the sector is still at a nascent stage with most research focused on research and development rather than commercialization. Only a few AMP-based products currently exist on the market and the market is expected to expand over the coming years. While the potential for AMPs to replace antimicrobial drugs such as antibiotics in fighting infectious diseases is clear, challenges still remain on the technical and regulatory front, mainly regarding the formulation and large-scale production of these molecules, both of which remain financially unattractive.
The global Antimicrobial Peptides market was valued at US$ 5 million in 2022 and is anticipated to reach US$ 7 million by 2029, witnessing a CAGR of 5.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Antimicrobial Peptides Market available at: https://www.themarketreports.com/report/global-antimicrobial-peptides-market-research-report
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Peptides.
The major global companies of Antimicrobial Peptides include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, Zhongnong Yingtai Biotechnology, Glam Technology, ProteLight Pharmaceutical & Biotechnology etc. In 2021, the world’s top three vendors accounted for approximately % of the revenue.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1706497
Release by:
Shirish Gupta
Marketing Manager
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com